Copyright 2021 Robert Clark
There has been a present push to reopen the economies and the schools. Unfortunately, there has been a present surge in COVID-19 cases. Some countries particularly the Asian countries have COVID-19 death rates at 1/100th those in Western countries:
The pandemic appears to have spared Africa so far. Scientists are struggling to explain why.
Commenters on this difference have mentioned the first few of these as the cause. But quite puzzling is the aversion of those who have commented on the question to consider the possibility that difference in treatments might at least be a part of cause.
It is a well-known fact that antiviral therapies are best applied soon after infection, for example, for influenza and HIV. And this had been the recommendation of the CDC against the flu and the pandemic H1N1:
Filed Under: Influenza, General; H1N1 2009 Pandemic Influenza; Public Health
By: Robert Roos | Sep 08, 2009
Sep 8, 2009 (CIDRAP News) Revised recommendations from federal health officials on the use of influenza antiviral drugs suggest that clinicians consider providing prescriptions over the phone for high-risk patients as a way to start treatment faster if they come down with flu symptoms.
At the same time, the recommendations released today from the Centers for Disease Control and Prevention (CDC) suggest that clinicians try "watchful waiting" when high-risk patients have been exposed to flu but remain healthy, rather than prescribing a preventive antiviral right away. The recommendations cover both pandemic H1N1 and seasonal flu.
Shoya Iwanami, et. al.
Therapy for Early COVID-19
A Critical Need
Peter S. Kim, MD1; Sarah W. Read, MD, MHS1; Anthony S. Fauci, MD2
JAMA. 2020;324(21):2149-2150. doi:10.1001/jama.2020.22813
Randomized Controlled Trials(RCT's) commonly take 3 months or more to complete, and then there still can be complaints it didn't have enough study participants to form firm conclusions. Here I'm arguing for RWE's, but conducted nationwide.
An advantage of RCT's is their randomized nature allows confounding factors to be accounted for. But RWE's conducted nationwide can accomplish the same thing because of the large number of cases and circumstances of the studies.
Indeed several authors have argued for these
reasons for RWE's:
May 11, 2018,12:25am EDT
Will Real World Performance Replace RCTs As Healthcare's Most Important Standard?
David Shaywitz Contributor
The Beneficial Impacts of Real-World Evidence in Drug Development
Posted on August 1st, 2019 by Xuanyan Xu in Pharma R&D
Real-world evidence, which is based on data that is gathered during routine clinical practice, has the potential to make a meaningful impact in nearly every phase of the life of a drug. That means RWE is relevant to:
Early discovery – “RWE has the potential to be used early in drug discovery and development programs, facilitating product development by identifying diseases or indications that represent a significant burden in populations,” explains this paper on real-world evidence, also noting the example of the NIH using electronic health records to support differentiation of patients’ needs.
Published online 2018 Aug 29. doi: 10.12688/f1000research.13585.2
Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Sajan Khosla 1, Robert White 2, Jesús Medina 3, Mario Ouwens 4, Cathy Emmas 5, Tim Koder 6, Gary Male 6, Sandra Leonard 2
PMID: 30026923 PMCID: PMC6039945 DOI: 10.12688/f1000research.13585.2
Doctors whose expertise is in rheumatic diseases for example could prescribe HCQ. They would be intimately familiar with its side effects and would know what to look for. And doctors for example who routinely prescribe interferon would know its side effects and contraindications. This way you could have a maximal safety approach while allowing a wide variety of different medications to be tested at the same time.
There are about a million doctors in the U.S. Imagine all that knowledge, all that experience, all that creativity, all being brought to bear in toto in finding effective treatments for this, and other diseases as well. Furthermore, imagine this all happening in real time, critically important in the midst of a pandemic.
A new possible treatment for COVID-19: interferon alpha.
Nathan Peiffer-Smadja, Yazdan Yazdanpanah
Published:November 12, 2020
Another is favipiravir for early treatment:
Posted: 26 Oct 2020
Tatiana Ruzhentsova, Pavel Chukhliaev, et.al.
November 16, 2020
Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial
Zarir F.Udwadiaa, et.al.
It is notable, and unfortunate, that these successful trials showing effective antiviral use when used early occurred in trials overseas.
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Prof Ivan Fan-Ngai Hung, MD et al.
Published:May 08, 2020
Anti-inflammatories for serious disease.
Some anti-inflammatories have shown to be effective for patients that need oxygen such as those on ventilators, including dexamethasone and tocilizumab. But the reduction in lung inflammation can be measured in real time by detecting markers such as IL-6 and CRP and even in CT scans. Then the effectiveness of these anti-inflammatories can also be observed on short time scales. See the discussion in the update dated from 6/26/2020 here:
There, is discussed this report:
Published: 15 May 2020
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
Bo Yu, Chenze Li, Peng Chen, Ning Zhou, Luyun Wang, Jia Li, Hualiang Jiang & Dao-Wen Wang
Science China Life Sciences (2020)
These data demonstrate that addition of HCQ on top of the basic treatments is highly effective in reducing the fatality of critically ill patients of COVID-19 through attenuation of inflammatory cytokine storm. Therefore, HCQ should be prescribed as a part of treatment for critically ill COVID-19 patients, with possible outcome of saving lives.
hydroxychloroquine, IL-6, mortalities, COVID-19
Quite notably the authors observed in real time a reduction in the level of IL-6, a key marker for inflammation, during the treatment with HCQ. So from both CT imaging and inflammation marker readings we could tell if HCQ or other anti-inflammatories were having a beneficial effect on patients under severe disease.
It is important to understand the reason why it was that several studies from Asian countries showed positive effects for HCQ while several studies in the Western countries did not.
After we examined several of the negative reports on HCQ published on Western studies, we observed multiple times that the effectiveness of HCQ was obscured in the presentation of their data. We will offer no hypotheses as to the reasons why its effectiveness was obscured in the reports on the Western studies.
For example, two of the most widely-cited negative HCQ reports by Geleris et al. and Rosenberg et al. omitted from the conclusions that the data showed HCQ cut mortality in half for ventilated patients. Adverse events for a medication must be reported, and this has been done extensively for HCQ. But by the same token, subcases with benefit for the medication should also be reported.
The report by Geleris et. al. here:
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
June 18, 2020
Editor’s Note: This article was published on May 7, 2020, at NEJM.org.
N Engl J Med 2020; 382:2411-2418
Left out of the paper itself, and included only in the Supplementary Appendix, was this Table:
You see the mortality in the HCQ group for intubated patients, i.e., those on invasive mechanical ventilation, was 49/154 = .318, or 31.8%. But the mortality for intubated patients for the non-HCQ group was 17/26 = .654, or 65.4%. So the mortality was halved in the HCQ group for intubated patients.
Actually, it may even be better than this. As an observational trial, the treated patients are likely not evenly distributed among patients with different comorbidities or with level of disease compared to the controls. Quite often the treatments are given to the sicker patients. Then usually in such observational studies as in this one statistical adjustments have to be made to compensate for the fact the sicker patients were given the medication which would skew the results against the treated group.
But in the Table S1 this appears to be just the raw data. Then after the statistical adjustments for HCQ being given to the sicker patients the mortality benefit for HCQ over the controls for ventilated patients might be even higher.
The Rosenberg et. al. paper is here:
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg, PhD1; Elizabeth M. Dufort, MD2; Tomoko Udo, PhD1; et al
JAMA. 2020;323(24):2493-2502. doi:10.1001/jama.2020.8630
The table showing the mortality specifically for ventilated patients from the supplementary file here:
You see HCQ used alone reduced mortality specifically for ventilated patients by a factor of 0.60 and HCQ used with AZT by a factor of 0.53. But once again this appeared not in the paper itself but only in a supplementary file.
It's dismaying that this data wasn't discussed among the conclusions the authors made in their articles. First of all appearing only in the supplementary files, not in the articles proper, very few people would have taken the time to find and read these tables, certainly not the science journalists reporting on the research and not even most doctors disseminating this information to the public at large and to the policy makers making decisions on use of HCQ.
But what's really dismaying is both of these took place in New York. In New York at the time the mortality for patients on ventilators was in the range of 80%:
USA TODAY Updated April 10, 2020
Doctors were desperate to find a treatment to help save ventilated patients lives, but the effectiveness of HCQ for those on ventilators was not made apparent to them.
The usefulness of HCQ for those on mechanical ventilation would have been even more apparent because of that report appearing in a Chinese journal that we cited above by Bo Yu et al., "Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19".
That report showed mortality cut by 60% for ventilated patients taking HCQ. But with the two widely cited American papers making a blanket statement of "no benefit", this Chinese report barely registered.
It's possible the authors and/or reviewers and/or editors calculated the significance levels and decided they didn't rise to the standard significance level of 0.05. If they did calculate the significance levels then they should have been reported in the papers. But in any case, all medical researchers are aware of the fact that a result not rising to statistical significance level does not mean the result is wrong. It could also simply mean the sample size wasn't large enough for it to rise to statistical significance.
All too often this qualifier is left out of reports on medical studies, and it is certainly left out on news reports on the studies. Then the public and other doctors are simply left with the incorrect conclusion that the treatment has been proven not to work.
With a difference this large of the deaths being cut in half for those on ventilators, the significance levels should have been reported in the papers. And it should have been acknowledged in the papers if the significance level wasn't at the standard level of 0.05 for the sample size used, that larger studies would be needed to determine if the result was real or just a statistical artifact.
As we mentioned, studies have shown multiple different anti-inflammatories such as steroids can be beneficial for COVID-19. Indeed this happened with dexamethasone in the RECOVERY trial, among others. It is simply unreasonable then to suppose HCQ as a very effective anti-inflammatory is not. It’s probably the reason so many HCQ studies, including ones claiming “no benefit”, did show benefit.
An astonishing instance of this occurred in the RECOVERY trial. The RECOVERY trial was a randomized-controlled trial (RCT), which are called the "gold-standard" of medical studies. Because it was negative towards HCQ, it was frequently cited as evidence of HCQ having no effect.
RCT's aren't perfect of course. There can be flaws in interpreting the data, there may not be sufficient numbers of subjects to draw a strong conclusion. They can use the wrong dosage, etc. And unfortunately there can also be cases where researchers falsify data.
We do not consider this last possibility likely to be the case with the RECOVERY trial. However, what we found did happen in the RECOVERY trial was nearly as bad in regards to accurately assessing the effectiveness of HCQ: while the data presented was correct, the way it was presented obscured the HCQ effectiveness.
Here's the HCQ report from the RECOVERY trial:
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group
November 19, 2020
N Engl J Med 2020; 383:2030-2040
You see instead of deaths on mechanical ventilation being given directly, it is combined with all deaths into one category. This is called a "composite endpoint" or "composite outcome". So, we need to do the calculation to find the proportion of the ventilated patients who died on HCQ and then calculate the proportion for those not on HCQ who died, since these are not given directly. Use the formula for counting the number of elements in the union of two sets with possible overlap:
which simply means you add together the number in each set, then subtract off the number in the overlap.
What's given in the report is the union of the two sets of the ventilated and of the deaths. But what we want is the intersection, those who were ventilated that died. So we'll turn around that formula for the number in the union to get the number in the intersection as, | A ⋂ B | = |A| + |B| - | A ⋃ B |.
So in this case, |ventilated ⋂ deaths| = |ventilated| + |deaths| - |ventilated ⋃ deaths|. First look at the cases on HCQ. From Table 2, for those on HCQ, |ventilated⋂deaths| = |ventilated| + |deaths| - |ventilated ⋃ deaths| =128+311- 399 = 40. So on HCQ, the rate of deaths on ventilator 40/128 = 0.312, 31.2%.
Now calculate it for the non-HCQ group, i.e., the usual care group. The numbers appear in the "Usual care" column in the table. So in this case, |ventilated ⋂ deaths| = |ventilated| + |deaths| - |ventilated ⋃ deaths|. First look at the cases on HCQ. From Table 2, for those HCQ, |ventilated⋂deaths| = |ventilated| + |deaths| - |ventilated ⋃ deaths| = 225 + 574 - 705 = 94, so the rate of deaths on ventilator is 94/225 = 0.417, or 41.7%. This difference between the number of ventilated patients on HCQ who died of 32.2% and those not on HCQ who died of 42.3% is large enough that it should have been reported.
The RECOVERY trial made headlines world-wide when it sent out a news release on the "breakthrough" that the steroid dexamethasone could cut mortality for ventilated patients by 30%.
Here is the published article on the discovery:
The RECOVERY Collaborative Group
July 17, 2020DOI: 10.1056/NEJMoa2021436
Note that all of the Geleris et al., Rosenberg et al., and the RECOVERY trials could legitimately report that overall there was no statistical difference by using HCQ. But this was because for the important subcase of ventilated patients, their numbers were a small proportion of the total number of cases. However, the large difference using HCQ for that key subcase of ventilated patients should have been reported.
Another instance where positive effects of HCQ were obscured was in a paper by Tang et al. In this case though the positive effects weren't just obscured, they were actually deleted:
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1849 (Published 14 May 2020)
Tang et al. is regarded as a negative HCQ paper, but deleted from the published version was this passage in the preprint:
"In addition to virus infection, acute inflammation response is another hallmark of COVID-19.19
Recent findings in clinical series have shown that the systemic inflammation or cytokine storm is
the driver of disease progression and death.20,21 Substantially decrease of lymphocyte count and increase of inflammatory response marker, e.g., CRP were both observed in the early stage of patients who eventually progressed and died.21 These results highlighted the importance of the recovery of lymphopenia or anti-inflammation in preventing the development of systemic
inflammation in critically ill COVID-19 patients. Such abilities and benefits were observed from
HCQ in our current trial, showing that patients with SOC plus HCQ had a significantly greater
reduction of CRP level and a moderate elevation of blood lymphocyte count at the last assessment comparing to patients with SOC only. These effects were observed after 5-day of HCQ treatment and maintained until the withdraw of HCQ. These encouraging results suggested clinical benefits of adding HCQ into the current standard management to limit inflammatory response, which is the key to prevent systemic inflammation and subsequent multiple organ failure and death."
The extensive list of benefits of HCQ seen by the Tang et al. research group, that were deleted from the published report was discussed by Dr. Didier Raoult here:
It is extremely unfortunate these details were deleted from the final report. Note this study appeared around the same time as the Geleris et al. and Rosenberg et al. reports in May. Since it shows HCQ effectiveness as an anti-inflammatory, if the Tang published report and the two Geleris and Rosengberg published reports had revealed these positive effects of HCQ, then coupled with the positive results of the Bo Yu et al. report, doctors would have had an effective treatment approach to ventilated patients.
Some Western doctors and researchers may choose to believe the Western studies rather than the Asian studies. But given the fact the death rates in the Asian countries are 1/100th those in the West, I would not be so sanguine about that choice.
As with the antivirals, the Real World Experience approach should be used, with nearby hospitals testing different anti-inflammatories so the comparisons can be made to their effectiveness without confounding factors. And as with the antivirals the comparisons among the various hospitals should be done in real time. And also as with the antivirals the effectiveness of the anti-inflammatories might be seen within days by looking in real-time the presence of the inflammation markers such as IL-6 and CRP, and at the CT scans. The importance of the CT scans is that the improvement in the degree of lung inflammation can literally be seen by the doctors as the treatment progresses:
CT scans can detect coronavirus in patients before RT-PCR lab testing
NEWS | COMPUTED TOMOGRAPHY (CT) | FEBRUARY 26, 2020 | MELINDA TASCHETTA-MILLANE AND DAVE FORNELL
In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19)
Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology
Rapid identification of COVID-19 severity in CT scans through classification of deep features.
Zekuan Yu, Xiaohu Li, Haitao Sun, Jian Wang, Tongtong Zhao, Hongyi Chen, Yichuan Ma, Shujin Zhu & Zongyu Xie
BioMedical Engineering OnLine volume 19, Article number: 63 (2020)
The observational difference in the appearance of coronavirus inflamed areas of the lung are made apparent in this 3D CT scan:
CT scan shows damaged tissue from a covid-19 patient's lungs.
Apr 1, 2020
Dr. Marcus Chen's research involves making #CT scans safer by reducing the amount of radiation by over 90%. This chest CT shows a stunning view of a #COVID19 patient's lungs. The yellow areas represent normal lung tissue, while the blue areas are damaged tissue. #ImageOfTheWeek
3:12 PM · Aug 5, 2020·Twitter Web App
Department of Mathematics
Chester, PA 19013
Sars-CoV-2/Covid-19 seems to attack more and different organs than most other viruses. Its unique and long-lasting effects seem to derive from that characteristic, as near as I can tell. That is why developing treatments is so important. As for higher death rates in the US, my hypothesis is that two things drive the bulk of that: (1) political-motivated resistance to masks and distancing on the part of half the population, and (2) a population with more underlying health problems generally. Mostly because of cause (1), we in the US are on track for this disease's death toll to exceed that of the 1918 pandemic, and in a shorter period of time. A similar thing happened in 1918, according to the accounts I have read. -- GWReplyDelete
It was during my research on HIV/Herpes that I stumbled upon the Hiv/Herpes information; information which is quite easy to find when doing a search for STD on google. I was into conspiracy at the time thought of HIV/Herpes Cured' being a conspiracy was something Ignorance though,I found pretty interesting about herbal medicine. I asked questions about the Herbal cure's on official HIV/Herpes websites and I was banned for doing so by moderators who told me that I was parroting Hiv/Herpes propaganda. This reinforced my belief that there is a cure for Hiv/Herpes Then i found a lady from germany name Achima Abelard Dr Itua Cure her Hiv so I send him a mail about my situation then talk more about it and send me his herbal medicine I drank for two weeks.And today I'm Cured no Hiv/Herpes in my life,I searched for Hiv/Herpes groups to attempt to make contact with people in order to learn more about Hiv/Herpes Herbal Cure's I believed at this time that you with the same disease this information is helpful to you and I wanted to do the best I could to spread this information in the hopes of helping other people.That Dr Itua Herbal Medicine makes me believes there is a hope for people suffering from,Parkinson's,Alzheimer’s disease,Bechet’s disease,Crohn’s disease,Cushing’s disease,Heart failure,Multiple Sclerosis,Hypertension,Colo_Rectal Cancer,Lyme Disease,Blood Cancer,Brain Cancer,Breast Cancer,Lung Cancer,Kidney Cancer,Love Spell,psoriasis,Lottery Spell,disease,Schizophrenia,Cancer,Scoliosis,Fibromyalgia,Fluoroquinolone Toxicity Syndrome Fibrodysplasia Ossificans Progressiva.Infertility,Tach Disease ,Epilepsy ,Diabetes ,Coeliac disease,,Arthritis,Amyotrophic Lateral Sclerosis,Autism,Alzheimer's disease,Adrenocortical carcinoma.Asthma, (measles, tetanus, whooping cough, tuberculosis, polio and diphtheria)Allergic diseases.Parkinson's disease,Schizophrenia,Lung Cancer,Breast Cancer,Colo-Rectal Cancer,Blood Cancer,Prostate Cancer,siva.Fatal Familial Insomnia Factor V Leiden Mutation ,Epilepsy Dupuytren's disease,Desmoplastic small-round-cell tumor Diabetes ,Coeliac disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Scoliosis,Fibromyalgia,Fluoroquinolone ToxicitySyndrome Fibrodysplasia Ossificans ProgresSclerosis,Seizures,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic diseases.Hiv_ Aids,Herpe ,Copd,Glaucoma., Cataracts,Macular degeneration,Cardiovascular disease,Lung disease.Enlarged prostate,Osteoporosis.ReplyDelete
Dementia.Lung Cancer, Leukemia Lymphoma Cancer,Lung Mesothelioma Asbestos,
Ovarian Cervical Uterine Cancer,
Skin Cancer, Brain Tumor, ,Hiv_ Aids,Herpes,Inflammatory bowel disease ,Copd,Diabetes,Hepatitis,Lupus,I read about him online how he cure Tasha and Tara,Conley,Mckinney and many more suffring from all kind of disease so i contacted him . He's a herbal doctor with a unique heart of God, Contact Emal. ... firstname.lastname@example.org Phone or whatsapp..+2348149277967.
There are some natural remedies that can be used in the prevention and elimination of diabetes totally. However, the single most important aspect of a diabetes control plan is adopting a wholesome lifestyle Inner Peace, Nutritious and Healthy Diet, and Regular Physical Exercise. A state of inner peace and self-contentment is essential to enjoying a good physical health and overall well-being. The inner peace and self contentment is a just a state of mind.People with diabetes diseases often use complementary and alternative medicine. I was diagnosed with diabetes .It was at work and feeling unusually tired and sleepy. I borrowed a cyclometer from a co-worker and tested at 760. Went immediately to my doctor and he gave me prescriptions like: Insulin ,Sulfonamides,Thiazolidinediones but Could not get the cure rather to reduce the pain but bring back the pain again. i found a woman testimony name Comfort online how Dr Akhigbe cure her HIV and I also contacted the doctor and after I took his medication as instructed, I am now completely free from diabetes by doctor Akhigbe herbal medicine.So diabetes patients reading this testimony to contact his email email@example.com or his Number +234 802 501 2866 He also use his herbal herbs to diseases like:SPIDER BITE, SCHIZOPHRENIA, LUPUS,EXTERNAL INFECTION, COMMON COLD, JOINT PAIN, EPILEPSY,STROKE,TUBERCULOSIS ,STOMACH DISEASE. ECZEMA, GOUT, PROGENITOR, EATING DISORDER, LOWER RESPIRATORY INFECTION, DIABETICS,HERPES,HIV/AIDS, ;ALS, CANCER , TUMOR MENINGITIS,HEPATITIS A AND B,ASTHMA, HEART DISEASE, CHRONIC DISEASE. NAUSEA VOMITING OR DIARRHEA,KIDNEY DISEASE. HEARING LOSSDr Akhigbe is a good man and he heal anybody that comes to him. here is email firstname.lastname@example.org and his Number +234 901 075 4824ReplyDelete
Hello, I want to write a little review about the good work of doctor ehiaguna, who cured me from HSV 1&2 for just 2 week with his herbal medicine, I never believe I can be cured again and have a good life like others, I always regretted the day I got diagnose with this virus, I become lost of hope when my doctor told me there is no cure for it, Well I am so grateful for my helper who get me cured with his herbal medicine, I went online in search of anything that can help me because I can’t deal with it forever so I found dr ehiaguna email email@example.com on a Facebook of someone who was cured by him,of the same herpes, so I quickly contacted him for help and explained all my pains to him, he told me not to worry about it there is a cure for real, I never believe until he sent me the herbs when I ordered for it and I got it within 5 working days that is how I took the medicine for 2 weeks and the following week I went for a test just to confirm I was 100% cured from this sickness what a miracle in my life, I am so happy right now, and forever greatful, you can also get in contact with him if you have such sickness through his whatsapp +2348073908953 you can email him:: firstname.lastname@example.org visit his website. https://effectiveherbalcurehome.blogspot.com/ God bless youReplyDelete
The greatest Joy in my life today is that i have been cured of Herpes by a Doctor called Dr Ogudugu, I was infected with HERPES Disease in 2019, i went to many hospitals for cure but there was no solution, so I was thinking how can I get a solution,so that my body can be okay. Until one faithful day as i was browsing on the internet I saw a testimony on how Dr Ogudugu has helped people in curing Herpes and other diseases, quickly copied his WhatsApp number so i contacted him for solution for my Herpes disease, So Dr Ogudugu told me that his going to prepare his herbal medicine for my health which he sent to me, luckily after 2week my Herpes was cured. Dr Ogudugu is well recognize as one of the best herbalist doctor in Africa, you don't have to be sad anymore or cry anymore on this disease when the cure is available. The medicine has NO SIDE EFFECT,there's no special diet when taking the medicine. He also cure ALS, HIV AIDS, CANCER, HPV, DIABETES and lots more.ReplyDelete
My mom was diagnosed with Alzheimer's disease 7 years ago, almost when all hope was lost due to several failed attempts in making her healthy. My desire to see her permanently free drives me into searching the internet for possible solutions which led me to a video about Alzheimer’s disease on YouTube, I met with a comment on how an herbal doctor cures Alzheimer patients with natural herbs. I collected the doctor's contact and reached out to him, we talked about it and he asked few questions about her physical challenges which I answered, and then he prepared the herbal medicine and sent them to me here in Tennessee with prescriptions on how to use attached, I ensured my mom took the herbal medicine accordingly and in 3 weeks of using this medication, we began to see improvement in her health and now, I am so glad to share this testimony that after 8 months, my mom is permanently healed from this horrible disease called Alzheimer, and now she is living her best life. Contact Dr. Rohan via email@example.com you will come back for your testimony.ReplyDelete
This is so amazing and so much reminds me of my Dad’s battle with Parkinson's disease and stroke. I think the biggest trauma was much on the family. You know, watching your agile father became so fragile and a shadow of himself. He became dependent on grand kids to move him around and feed too. It was really heartbreaking for everyone! But each time I remember the story, I become so thankful that we were opportune to learn about Dr. OVIE through the internet and used his herbal medicine which helped my Dad. Though I read a lot of negative things about herbs for Parkinson's disease and attendant effects of stroke treatment, I can tell you that the right herbal medicine is still out there! We found ours through Ovie. My Dad was 75 when he had an attack with Parkinson's disease which led to stroke. We used all recommended over-the-counter medicines for him for a period of 3 years, yet, there was no cure and to think those drugs had very bad side effects on him became our new challenge. When we switched to homeopathic treatment, he got a little better. Our breakthrough was through Dr. OVIE Herbal Medicine. That medicine was a miracle our family will never forget. In 2 months of use, his body was totally revived! His stroke vanished while Parkinson's disease was completely cured. Dad turned 87 august 01 th and is still very strong. Occasionally tending his garden with grandchildren. I will say, give Ovie a try, you never know your breakthrough from Parkinson's disease and stroke is very close to you an email away. ontact Dr Ovie via email> firstname.lastname@example.org or contact Dr Ovie on yahoo email> email@example.com contact Dr.Ovie on his website now https://oviemiraclemedicin.wixsite.com/mysite Call or WhatsApp Dr on +2349056393169 aaDr Ovie is also specialize in curing the following below,*PARKINSON DISEASEReplyDelete
I already gave up on ever getting cured of HSV2 because I have try many treatment none of them work out for me I have be to different hospital they always tell me same thing there is no cure for herpes when i came across a post about Dr momoh, in the net from a lady called Rebecca I contacted him and he reassured me with his herbal medicine which I took according to the way he instructed, that how i was cured. I doubted at first because I have been to a whole lot of reputable doctors, tried a lot of medicines but none was able to cure me. so I decided to listen to him and he commenced treatment, and under two weeks I was totally free from Herpes. I want to say a very big thank you to DR momoh for what he has done in my life. feel free to leave him a message on email firstname.lastname@example.org and also WhatsApp him +2347083724098.. or visit his website https://drmomohherbaltreatment.wordpress.com. He can still be able to help you with this herbs medicine: 1...ALS CURE/DIABETES CURE/EPILESY/HPV CURE/LUPUS/HEPATITIS/CANCER/GOUTReplyDelete